Vol. 57 No. 1 (2018): Acta Oncologica

Articles

• Provision of data from the clinical database and of biological material from the tumor bank of the Danish Breast Cancer Cooperative Group 2008–2017

  Henning Mouridsen, Peer Christiansen, Maj-Britt Jensen, Anne-Vibeke Laenkholm, Henrik Flyger, Birgitte Offersen, Ilse Vejborg, Bent Ejlertsen

  154-156

  Published: 2018-01-02

  • PDF

• Occult breast cancer in breast reduction specimens

  Lotte Meyer, Camilla Bille, Thomas Foged, Anne Marie Bak Jylling

  170-173

  Published: 2018-01-02

  • PDF

• The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016

  Maj-Britt Jensen, Anne-Vibeke Laenkholm, Birgitte V. Offersen, Peer Christiansen, Niels Kroman, Henning T. Mouridsen, Bent Ejlertsen

  13-18

  Published: 2018-01-02

  • PDF

• The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes

  Anne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, Wesley Buckingham, Sean Ferree, Torsten O. Nielsen, Bent Ejlertsen

  44-50

  Published: 2018-01-02

  • PDF

• An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

  Anne-Vibeke Laenkholm, Dorthe Grabau, Maj-Lis Møller Talman, Eva Balslev, Anne Marie Bak Jylling, Tomasz Piotr Tabor, Morten Johansen, Anja Brügmann, Giedrius Lelkaitis, Tina Di Caterino, Henrik Mygind, Thomas Poulsen, Henrik Mertz, Gorm Søndergaard, Birgitte Bruun Rasmussen

  83-89

  Published: 2018-01-02

  • PDF

• The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial

  Martin Berg, Ebbe L. Lorenzen, Ingelise Jensen, Mette S. Thomsen, Christina Maria Lutz, Lasse Refsgaard, Henrik D. Nissen, Birgitte V. Offersen

  113-119

  Published: 2018-01-02

  • PDF

• Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study

  Gitte Lee Mortensen, Ivan Bredbjerg Madsen, Randi Krogsgaard, Bent Ejlertsen

  146-151

  Published: 2018-01-02

  • PDF

• The accuracy of preoperative staging of the axilla in primary breast cancer: a national register based study on behalf of Danish Breast Cancer Group (DBCG)

  Kristine Hamran, Linnea Langhans, Ilse Vejborg, Tove Filtenborg Tvedskov, Niels Kroman

  162-166

  Published: 2018-01-02

  • PDF

• Is DBCG abreast of new developments?

  Birgitte V. Offersen, Bent Ejlertsen, Eva Balslev, Henrik Flyger, Anne-Marie Gerdes, Mads K. Hansen, Lisbet R. Hølmich, Maj-Britt Jensen, Bent Kristensen, Anne-Vibeke Laenkholm, Henning T. Mouridsen, Mette H. Nielsen, Jens Overgaard, Malgorzata Tuxen, Ilse Vejborg, Peer Christiansen

  1-2

  Published: 2018-01-02

  • PDF

• Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG)

  Signe Korsgaard Skriver, Anne-Vibeke Laenkholm, Birgitte Bruun Rasmussen, Jürgen Handler, Bo Grundtmann, Tove Filtenborg Tvedskov, Peer Christiansen, Ann S. Knoop, Maj-Britt Jensen, Bent Ejlertsen

  31-37

  Published: 2018-01-02

  • PDF

• Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer

  Anne E. Lykkesfeldt, Benedikte R. Iversen, Maj-Britt Jensen, Bent Ejlertsen, Anita Giobbie-Hurder, Birgit E. Reiter, Tove Kirkegaard, Birgitte B. Rasmussen

  67-73

  Published: 2018-01-02

  • PDF

• Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer

  Trine Tramm, Marianne Kyndi, Flemming B. Sørensen

  102-106

  Published: 2018-01-02

• Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials

  Maj-Britt Jensen, Torsten O. Nielsen, Ann S. Knoop, Anne-Vibeke Laenkholm, Eva Balslev, Bent Ejlertsen

  135-140

  Published: 2018-01-02

  • PDF

• Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer

  Lena H. Rosvig, Sven T. Langkjer, Ann Knoop, Anders B. Jensen

  156-159

  Published: 2018-01-02

  • PDF

• Breast conserving surgery versus mastectomy: overall and relative survival—a population based study by the Danish Breast Cancer Cooperative Group (DBCG)

  Peer Christiansen, Stina Lyck Carstensen, Bent Ejlertsen, Niels Kroman, Birgitte Offersen, Anne Bodilsen, Maj-Britt Jensen

  19-25

  Published: 2018-01-02

  • PDF

• Characterization of basal-like subtype in a Danish consecutive primary breast cancer cohort

  Savvas Kinalis, Finn Cilius Nielsen, Maj-Lis Talman, Bent Ejlertsen, Maria Rossing

  51-57

  Published: 2018-01-02

  • PDF

• Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists

  Trine Tramm, Tina Di Caterino, Anne-Marie B. Jylling, Giedrius Lelkaitis, Anne-Vibeke Lænkholm, Péter Ragó, Tomasz P. Tabor, Maj-Lis M. Talman, Emmanouela Vouza

  90-94

  Published: 2018-01-02

  • PDF

• Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database

  Deirdre Cronin-Fenton, Timothy L. Lash, Thomas P. Ahern, Per Damkier, Peer Christiansen, Bent Ejlertsen, Henrik T. Sørensen

  120-128

  Published: 2018-01-02

  • PDF

• Breast cancer patient advocacy in Denmark

  Eva Bundesen

  152-153

  Published: 2018-01-02

• Axillary lymph node dissection in breast cancer patients after sentinel node biopsy*

  Christina Jessing, Linnea Langhans, Maj-Britt Jensen, Maj-Lis Talman, Tove Filtenborg Tvedskov, Niels Kroman

  166-169

  Published: 2018-01-02

  • PDF

• Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration

  Bent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, Peer Christiansen, Maj-Britt Jensen, Niels Kroman, Ann Søgaard Knoop, Henning Mouridsen

  3-12

  Published: 2018-01-02

  • PDF

• Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy – results from two independent randomized trials

  Tinne Laurberg, Trine Tramm, Torsten Nielsen, Jan Alsner, Silje Nord, Simen Myhre, Therese Sørlie, Samuel Leung, Cheng Fan, Charles Perou, Karen Gelmon, Jens Overgaard, David Voduc, Aleix Prat, Maggie Chon U. Cheang

  38-43

  Published: 2018-01-02

  • PDF

• Triple negative breast cancer – prognostic role of immune-related factors: a systematic review

  Elisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, Eva Balslev

  74-82

  Published: 2018-01-02

  • PDF

• DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting

  Carsten Brink, Ebbe L. Lorenzen, Simon Long Krogh, Jonas Westberg, Martin Berg, Ingelise Jensen, Mette Skovhus Thomsen, Esben Svitzer Yates, Birgitte Vrou Offersen

  107-112

  Published: 2018-01-02

  • PDF

• The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study

  Bent Kristensen, Bent Ejlertsen, Maj-Britt Jensen, Henning T. Mouridsen

  141-145

  Published: 2018-01-02

  • PDF

• A Danish national effort of BRCA1/2 variant classification

  Inge Søkilde Pedersen, Ane Y. Schmidt, Birgitte Bertelsen, Anja Ernst, Christian Liebst Toft Andersen, Torben Kruse, Maria Rossing, Mads Thomassen

  159-162

  Published: 2018-01-02

  • PDF

• Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial

  Maj-Britt Jensen, Jens Fabricius Krarup, Torben Palshof, Henning T. Mouridsen, Bent Ejlertsen

  26-30

  Published: 2018-01-02

  • PDF

• Molecular subtyping of breast cancer improves identification of both high and low risk patients

  Maria Rossing, Olga Østrup, Wiktor W. Majewski, Savvas Kinalis, Maj-Britt Jensen, Ann Knoop, Niels Kroman, Maj-Lis Talman, Thomas V. O. Hansen, Bent Ejlertsen, Finn C. Nielsen

  58-66

  Published: 2018-01-02

  • PDF

• Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG

  I. M. H. Soenderstrup, A. V. Laenkholm, M. B. Jensen, J. O. Eriksen, A. M. Gerdes, T. V. O. Hansen, T. A. Kruse, M. J. Larsen, I. S. Pedersen, M. Rossing, M. Thomassen, B. Ejlertsen

  95-101

  Published: 2018-01-02

  • PDF

• Influence of specific comorbidities on survival after early-stage breast cancer

  Marianne Ewertz, Lotte Holm Land, Susanne Oksbjerg Dalton, Deirdre Cronin-Fenton, Maj-Britt Jensen

  129-134

  Published: 2018-01-02

  • PDF